Lista de obras -

A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.

artículo científico publicado en 2007

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis

artículo científico publicado en 2005

Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites.

artículo científico publicado en 2006

Concomitant early mucosal and cutaneous leishmaniasis in Brazil

artículo científico publicado en 2006

Corrigendum to "Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease".

artículo científico publicado en 2018

Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?

artículo científico publicado en 2008

DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis

artículo científico publicado en 2011

Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites

artículo científico publicado en 2016

Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease

artículo científico publicado en 2016

Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear

artículo científico publicado en 2013

Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva

artículo científico publicado en 2007

Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis

artículo científico publicado en 2013

Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection.

artículo científico publicado en 2013

Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses.

artículo científico publicado en 2002

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis

scientific article published on 01 March 2020

Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis

artículo científico publicado en 2010

Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva

artículo científico publicado en 2008

Inflammasome activation by CD8+ T cells from Patients with Cutaneous Leishmaniasis caused by Leishmania braziliensis in the immunopathogenesis of the disease

artículo científico publicado en 2020

Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

artículo científico publicado en 2018

Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.

artículo científico publicado en 2008

Leishmania amazonensis infection impairs differentiation and function of human dendritic cells

scientific article published on 21 September 2007

Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice

artículo científico publicado en 2004

Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils

artículo científico publicado en 2011

Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia

artículo científico publicado en 2011

Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View

Neutrophils and Macrophages Cooperate in Host Resistance against Leishmania braziliensis Infection

artículo científico publicado en 2009

New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis

artículo científico publicado en 2012

New Role of P. brasiliensis α-Glucan: Differentiation of Non-conventional Dendritic Cells

artículo científico publicado en 2019

PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania

artículo científico publicado en 2013

Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens

artículo científico publicado en 2006

Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa.

artículo científico publicado en 2018

Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment.

artículo científico publicado en 2005

Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection

article

Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity.

artículo científico publicado en 2002

The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis.

artículo científico publicado en 2012

Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis

artículo científico publicado en 2005

Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11

artículo científico publicado en 2012

Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophils

artículo científico publicado en 2014

Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis

artículo científico publicado en 2012

Vaccines in leishmaniasis: advances in the last five years

artículo científico publicado en 2003

Lista de obras de

A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis

Characterization of the T-cell receptor Vbeta repertoire in the human immune response against Leishmania parasites.

Concomitant early mucosal and cutaneous leishmaniasis in Brazil

Corrigendum to "Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease".

Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?

DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis

Degranulating Neutrophils Promote Leukotriene B4 Production by Infected Macrophages To Kill Leishmania amazonensis Parasites

Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease

Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear

Enhanced Leishmania braziliensis infection following pre-exposure to sandfly saliva

Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis

Functional transcriptomics of wild-caught Lutzomyia intermedia salivary glands: identification of a protective salivary protein against Leishmania braziliensis infection.

Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses.

Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis

Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis

Immunomodulation of human monocytes following exposure to Lutzomyia intermedia saliva

Inflammasome activation by CD8+ T cells from Patients with Cutaneous Leishmaniasis caused by Leishmania braziliensis in the immunopathogenesis of the disease

Integrated Analysis Reveals That miR-193b, miR-671, and TREM-1 Correlate With a Good Response to Treatment of Human Localized Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.

Leishmania amazonensis infection impairs differentiation and function of human dendritic cells

Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice

Lutzomyia longipalpis saliva drives apoptosis and enhances parasite burden in neutrophils

Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia

Molecular Aspects of Dendritic Cell Activation in Leishmaniasis: An Immunobiological View

Neutrophils and Macrophages Cooperate in Host Resistance against Leishmania braziliensis Infection

New Insights on the Inflammatory Role of Lutzomyia longipalpis Saliva in Leishmaniasis

New Role of P. brasiliensis α-Glucan: Differentiation of Non-conventional Dendritic Cells

PLGA nanoparticles loaded with KMP-11 stimulate innate immunity and induce the killing of Leishmania

Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens

Plant-feeding phlebotomine sand flies, vectors of leishmaniasis, prefer Cannabis sativa.

Saliva from Lutzomyia longipalpis induces CC chemokine ligand 2/monocyte chemoattractant protein-1 expression and macrophage recruitment.

Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection

Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity.

The presence of Tregs does not preclude immunity to reinfection with Leishmania braziliensis.

Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis

Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11

Understanding the mechanisms controlling Leishmania amazonensis infection in vitro: the role of LTB4 derived from human neutrophils

Vaccination with L. infantum chagasi nucleosomal histones confers protection against new world cutaneous leishmaniasis caused by Leishmania braziliensis

Vaccines in leishmaniasis: advances in the last five years